Viewing Study NCT07249060


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-01-27 @ 1:22 PM
Study NCT ID: NCT07249060
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Sponsor: Hospital Universitario Araba
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: PI_2023/90
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View